Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the ...

Here's the list of options activity happening in today's session: These itemized elaborations have been created using the ...

Investing in healthcare stocks has perhaps never been a better idea. The healthcare sector has grown significantly since the start of 2020, aided in large part by increased medical spending during ...

Cigna’s quarterly earnings fell well short of Wall Street’s expectations, as high healthcare costs hurt results in a segment of its insurance business. The company, parent of a pharmacy-benefit ...

The move is the latest sign that the pharmacy chain is struggling to cut costs, improve margins and find stability.

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...